Drug pricing decisions should be transparent, says finminPublished on: July 25, 2026 3:00 AM
Pakistan, July 25 -- Federal Minister for Finance and Revenue, Senator Muhammad Aurangzeb, chaired the 8th meeting of the Cabinet Committee constituted by the Prime Minister to consider the recommendations of the Drug Pricing Committee and the Policy Board of the Drug Regulatory Authority of Pakistan (DRAP). The meeting was attended by Federal Minister for National Health Services, Regulations and Coordination, Syed Mustafa Kamal and Federal Minister for Defense Production, Muhammad Raza Hayat Harraj.
The Committee received a detailed presentation from DRAP on recommendations relating to new drug price fixation cases, hardship applications, pricing matters and the availability of essential medicines. The presentation also provided an upd...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.